1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceuticals in Australia

Pharmaceuticals in Australia

  • September 2016
  • -
  • MarketLine
  • -
  • 40 pages

Summary

Table of Contents

Search Inside

Summary
Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Australia

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Australia

Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Australia pharmaceuticals market with five year forecasts

Synopsis
Essential resource for top-line data and analysis covering the Australia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons To Buy
What was the size of the Australia pharmaceuticals market by value in 2015?

What will be the size of the Australia pharmaceuticals market in 2020?

What factors are affecting the strength of competition in the Australia pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitors in Australia's pharmaceuticals market?

Key Highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.

The Australian pharmaceuticals market had total revenues of $19.1bn in 2015, representing a compound annual growth rate (CAGR) of 2.6% between 2011 and 2015.

Factors driving growth in Australia's pharmaceuticals are similar to many other developed markets including the increasingly elderly population and its associated disease burden.

The performance of the market is forecast to accelerate, with an anticipated CAGR of 3% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $22.1bn by the end of 2020.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.